Literature DB >> 30802354

Versatile Synthetic Route to Cycloheximide and Analogues That Potently Inhibit Translation Elongation.

Yongho Park1, Yumi Koga1, Cindy Su1, Amanda L Waterbury1, Christopher L Johnny1, Brian B Liau1.   

Abstract

Cycloheximide (CHX) is an inhibitor of eukaryotic translation elongation that has played an essential role in the study of protein synthesis. Despite its ubiquity, few studies have been directed towards accessing synthetic CHX derivatives, even though such efforts may lead to protein synthesis inhibitors with improved or alternate properties. Described here is the total synthesis of CHX and analogues, and the establishment of structure-activity relationships (SAR) responsible for translation inhibition. The SAR studies aided the design of more potent compounds, one of which irreversibly blocks ribosomal elongation, preserves polysome profiles, and may be a broadly useful tool for investigating protein synthesis.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  inhibitors; polysomes; proteins; structure-activity relationships; total synthesis

Year:  2019        PMID: 30802354     DOI: 10.1002/anie.201901386

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  7 in total

1.  Discovery of C13-Aminobenzoyl Cycloheximide Derivatives that Potently Inhibit Translation Elongation.

Authors:  Yumi Koga; Eileen M Hoang; Yongho Park; Alexander F A Keszei; Jason Murray; Sichen Shao; Brian B Liau
Journal:  J Am Chem Soc       Date:  2021-08-17       Impact factor: 16.383

Review 2.  A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis.

Authors:  S E Dmitriev; D O Vladimirov; K A Lashkevich
Journal:  Biochemistry (Mosc)       Date:  2020-11       Impact factor: 2.487

3.  Antiproliferative Activity and Potential Mechanism of Marine-Sourced Streptoglutarimide H against Lung Cancer Cells.

Authors:  Hengju Ge; Di Zhang; Muran Shi; Xiaoyuan Lian; Zhizhen Zhang
Journal:  Mar Drugs       Date:  2021-01-31       Impact factor: 5.118

4.  EGFR transcriptionally upregulates UTX via STAT3 in non-small cell lung cancer.

Authors:  Lin Zhou; Xiaomu Wang; Jingya Lu; Xiangning Fu; Yangkai Li
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-18       Impact factor: 4.553

5.  Multiplexed live-cell profiling with Raman probes.

Authors:  Chen Chen; Zhilun Zhao; Naixin Qian; Shixuan Wei; Fanghao Hu; Wei Min
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

Review 6.  Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies.

Authors:  Arnaud Gilles; Léo Frechin; Kundhavai Natchiar; Giulia Biondani; Ottilie von Loeffelholz; Samuel Holvec; Julie-Lisa Malaval; Jean-Yves Winum; Bruno P Klaholz; Jean-François Peyron
Journal:  Cells       Date:  2020-03-05       Impact factor: 6.600

7.  lncRNA MEG3 restrained the M1 polarization of microglia in acute spinal cord injury through the HuR/A20/NF-κB axis.

Authors:  Heng-Jun Zhou; Li-Qing Wang; Ren-Ya Zhan; Xiu-Jue Zheng; Jie-Sheng Zheng
Journal:  Brain Pathol       Date:  2022-03-25       Impact factor: 7.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.